Health24.com | Covid-19 antibody tests: Will they be reliable enough to manage the pandemic in the future?

  • There are currently two approved antibody tests for SARS-CoV-2.
  • These antibody tests can indicate if you’ve had Covid-19.
  • Experts are still unsure if this could determine immunity.

Countries around the world are slowly lifting hard lockdown restrictions to allow businesses and institutions to open safely without spurring another more severe wave of infections.

Many researchers agree that part of managing the pandemic involves determining who has already been exposed to SARS-CoV-2 and built up antibodies.

The method to do this? A reliable, accurate, readily-available antibody test.

There are, however, still a number of questions to be answered about whether an antibody test is possible and whether it will work.

What is an antibody test and what makes it different from the tests we already have?

An antibody test is not used as a diagnostic tool like the RT-PCR test and should not be used on a person who is showing symptoms.

The RT-PCR test is done when you are suspected of having contracted Covid-19. A swab is taken from the nasal passage or throat, and sent to a lab to check for viral material in the sample.

But the antibody test is different. This test looks for immunoglobin levels in the blood to tell whether you have had Covid-19 and built up antibodies.

Whenever your body is exposed to a pathogen such as a virus, the body’s immune system responds by producing protective measures to help you fight infection.

This agent is described as a Y-shaped molecule that attaches itself to foreign proteins such as bacteria and viruses and destroys infected cells, explains Patricia Slev who runs ARUP Laboratories, affiliated with the University of Utah.

How exactly does this test work to detect the antibodies in the blood?

According to a paper published in Chemical & Engineering News, antibody tests vary from manufacturer to manufacturer, but they all fulfil the same basic task – to detect antibodies.

Tests involve a tube of human blood being centrifuged to separate plasma from red blood cells. There is also another tube with bits of viral protein.

When the blood in the first tube has antibodies, it will be able to recognise the viral matter in the other tube and they will stick to each other.

This result means that there are antibodies present in the blood and that the person has had Covid-19 and has built immunity.

What is the current problem with these tests?

According to Shobita Parthasarathy, a science and public policy expert at the University of Michigan, many view antibody tests as a quick solution to determine whether an individual can safely venture back into society and as a tool for institutions such as businesses and schools to determine when they can reopen.

But, as she told Chemical & Engineering News, this is a lot of pressure to place on one test, as the scale of tests needed and the scope of their use in public can be ethically and logistically messy.

Earlier during the outbreak, there were several reports that these antibody tests might not be accurate and reliable and went onto the market without any regulation or standardising.

For example, the UK government spent £16 million on millions of tests – and none of them met the accuracy requirements when tested in laboratories.

But, according to Alex Greninger, a virologist and diagnostics expert at the University of Washington, these tests are slowly getting better, especially after the FDA demanded that they be validated.

The only tests currently approved are the Roche and Abbot tests, which were found to give 100% accurate results in people who had been infected with SARS-CoV-2.

If you have antibodies, are you immune?

When the antibody test has a positive result, it means that SARS-CoV-2 antibodies have been found in your blood and that you have been infected by Covid-19.

However, this doesn’t necessarily mean that you are completely immune to coronavirus, which defeats the purpose of using antibody tests as a proof of immunity to allow people back into society.

The truth is, scientists are not sure how much immunity you have after Covid-19 infection, even with the presence of antibodies.

Simply testing positive for antibodies doesn’t mean you can slack off on physical distancing and hygiene measures.

Another thing that the SARS-CoV-2 antibody tests can’t determine is how long these antibodies will last.

With some infections, the level of antibodies wears off over time, and that’s why booster vaccines are needed to help your body produce these antibodies again.

As we are still in the process of developing a vaccine, scientists also can’t tell whether these antibodies will last long enough.

But Greninger is positive that these antibodies can stick around for a long time, as early tests suggested that people with Covid-19 produce a large amount of antibodies and that the virus only mutates slowly.

How readily available will antibody tests be?

According to the paper in Chemical & Engineering News, Roche’s tests will reach a maximum production of tens of millions of tests for the entire globe by June, and Abbott also indicated mass production of these tests.

Currently the situation and availability for antibody tests in South Africa is not determined. Parthasarathy told Chemical & Engineering News that there is still concern about availability in the US alone as the demand will simply skyrocket.

A way back to normality?

So, will antibody tests be sufficient to allow us back into society?

Even though Greniger is optimistic about the future of these tests, other experts are still wary about rushing back to into society, as this might trigger a second wave of infections, and that the antibody tests are not yet able to tell us enough about our risks of getting reinfected.

READ | South Africa’s Covid-19 testing strategy needs urgent fixing: here’s how to do it

READ | Scientists warn of false-negatives with Covid-19 virus tests – what are the SA implications?

READ| Covid-19: Behind SA’s shortages of test material

Image credit: Pexels

Share Button

Coronavirus: ‘Start public inquiry now to prevent more deaths’

An immediate public inquiry could help save lives, say relatives of 450 virus victims.

Share Button

Half the earth relatively intact from global human influence

Roughly half of Earth’s ice-free land remains without significant human influence, according to a study from a team of international researchers led by the National Geographic Society and the University of California, Davis.

The study, published in the journal Global Change Biology, compared four recent global maps of the conversion of natural lands to anthropogenic land uses to reach its conclusions. The more impacted half of Earth’s lands includes cities, croplands, and places intensively ranched or mined.

“The encouraging takeaway from this study is that if we act quickly and decisively, there is a slim window in which we can still conserve roughly half of Earth’s land in a relatively intact state,” said lead author Jason Riggio, a postdoctoral scholar at the UC Davis Museum of Wildlife and Fish Biology.

The study, published June 5 on World Environment Day, aims to inform the upcoming global Convention on Biological Diversity — the Conference of Parties 15. The historic meeting was scheduled to occur in China this fall but was postponed due to the coronavirus pandemic. Among the meeting’s goals is to establish specific, and higher, targets for land and water protection.

Approximately 15 percent of the Earth’s land surface and 10 percent of the oceans are currently protected in some form. However, led by organizations including Nature Needs Half and the Half-Earth Project, there have been bold global calls for governments to commit to protecting 30 percent of the land and water by 2030 and 50 percent by 2050.

Intact natural lands across the globe can help purify air and water, recycle nutrients, enhance soil fertility and retention, pollinate plants, and break down waste products. The value of maintaining these vital ecosystem services to the human economy has been placed in the trillions of U.S. dollars annually.

CONSERVATION AND COVID-19

The coronavirus pandemic now shaking the globe illustrates the importance of maintaining natural lands to separate animal and human activity. The leading scientific evidence points to the likelihood that SARS-CoV2, the virus that causes the disease COVID-19, is a zoonotic virus that jumped from animals to humans. Ebola, bird flu and SARS are other diseases known to have spilled over into the human population from nonhuman animals.

“Human risk to diseases like COVID-19 could be reduced by halting the trade and sale of wildlife, and minimizing human intrusion into wild areas,” said senior author Andrew Jacobson, professor of GIS and conservation at Catawba College in North Carolina.

Jacobson said that regional and national land-use planning that identify and appropriately zone locations best suited to urban growth and agriculture could help control the spread of human development. Establishing protections for other landscapes, particularly those currently experiencing low human impacts, would also be beneficial.

FROM THE TUNDRA TO THE DESERT

Among the largest low-impact areas are broad stretches of boreal forests and tundra across northern Asia and North America and vast deserts like the Sahara in Africa and the Australian Outback. These areas tend to be colder and/or drier and less fit for agriculture.

“Though human land uses are increasingly threatening Earth’s remaining natural habitats, especially in warmer and more hospitable areas, nearly half of Earth still remains in areas without large-scale intensive use,” said co-author Erle Ellis, professor of geography at the University of Maryland-Baltimore County.

Areas having low human influence do not necessarily exclude people, livestock or sustainable management of resources. A balanced conservation response that addresses land sovereignty and weighs agriculture, settlement or other resource needs with the protection of ecosystem services and biodiversity is essential, the authors note.

“Achieving this balance will be necessary if we hope to meet ambitious conservation targets,” said Riggio. “But our study optimistically shows that these targets are still within reach.”

Share Button

Stiffer roadways could improve truck fuel efficiency

Every time you hear a deep rumble and feel your house shake when a big truck roars by, that’s partly because the weight of heavy vehicles causes a slight deflection in the road surface under them. It’s enough of a dip to make a difference to the trucks’ overall fuel efficiency.

Now, a theoretical study by MIT researchers suggests that small changes in roadway paving practices could reduce that efficiency loss, potentially eliminating a half-percent of the total greenhouse gas emissions from the transportation sector, at little to no cost.

The findings are detailed in a paper in the journal Transportation Research Record, by MIT postdoc Hessam Azarijafari, research scientist Jeremy Gregory, and principal research scientist in the Materials Research Laboratory Randolph Kirchain. The study examined state-by-state data on climate conditions, road lengths, materials properties, and road usage, and modeled different scenarios for pavement resurfacing practices.

They found that that one key to improving mileage efficiency is to make pavements that are stiffer, Kirchain explains. That reduces the amount of deflection, which reduces wear on the road but also reduces the slightly uphill motion the vehicle constantly has to make to rise out of its own depression in the road.

“When we as individuals walk on pavements, they seem like perfectly rigid things. They’re not responding to us,” he says. “But for trucks, that is not the case. There is enough of a deflection in that surface that some amount of energy is expended to overcome the little divot that you create as you drive along.” He likens it to the difference between walking on a hard surface versus walking on sand, which takes more effort because you sink in with each step.

Looking to the future, Kirchain says that while projections show a slight decline in passenger car travel over coming decades, they show an increase in truck travel for freight delivery — the kind where pavement deflection could be a factor in overall efficiency.

There are several ways to make roadways stiffer, the researchers say. One way is to add a very small amount of synthetic fibers or carbon nanotubes to the mix when laying asphalt. Just a tenth of a percent of the inexpensive material could dramatically improve its stiffness, they say. Another way of increasing rigidity is simply to adjust the grading of the different sizes of aggregate used in the mix, to allow for a denser overall mix with more rock and less binder.

“If there are high quality local materials available” to use in the asphalt or concrete mix, “we can use them to improve the stiffness, or we can just adjust the grading of the aggregates that we are using for these pavements,” says Azarijafari. And adding different fibers is “very inexpensive compared to the total cost of the mixture, but it can change the stiffness properties of the mixture significantly.”

Yet another way is to switch from asphalt pavement surfaces to concrete, which has a higher initial cost but is more durable, leading to equal or lower total lifecycle costs. Many road surfaces in northern U.S. states already use concrete, but asphalt is more prevalent in the south. There, it makes even more of a difference, because asphalt is especially subject to deflection in hot weather, whereas concrete surfaces are relatively unaffected by heat. Just upgrading the road surfaces in Texas alone, the study showed, could make a significant impact because of the state’s large network of asphalt roads and its high temperatures.

Kirchain, who is co-director of MIT’s Concrete Sustainability Hub, says that in carrying out this study, the team is “trying to understand what are some of the systemic environmental and economic impacts that are associated with a change to the use of concrete in particular in the pavement system.”

Even though the effects of pavement deflection may seem tiny, he says, “when you take into account the fact that the pavement is going to be there, with thousands of cars driving over it every day, for dozens of years, so a small effect on each one of those vehicles adds up to a significant amount of emissions over the years.” For purposes of this study, they looked at total emissions over the next 50 years and considered the reductions that would be achieved by improving anywhere from 2 percent of road surfaces to 10 percent each year.

With a 10 percent improvement rate, they calculated, a total of 440 megatons of carbon dioxide-equivalent emissions would be avoided over the 50 years, which is about 0.5 percent of total transportation-related emissions for this period.

The proposal may face some challenges, because changing the mix of materials in asphalt might affect its workability in the field, perhaps requiring adjustments to the equipment used. “That change in the field processing would have some cost to it as well,” Kirchain says.

But overall, implementing such changes could in many cases be as simple as changing the specifications required by state or local highway authorities. “These kinds of effects could be considered as part of the performance that’s trying to be managed,” Kirchain says. “It largely would be a choice from the state’s perspective, that either fuel use or climate impact would be something that would be included in the management, as opposed to just the surface performance of the system.”

Share Button

An aspirin a day keeps the bowel doctor away

A regular dose of aspirin to reduce the risk of inherited bowel cancer lasts at least 10 years after stopping treatment, research has revealed.

The international trial — known as CAPP2 — involved patients with Lynch syndrome from around the world and revealed that two aspirins a day, for an average of two and a half years, reduced the rate of bowel cancer by half.

The study, led by experts at the Universities of Newcastle and Leeds, UK, published in The Lancet today, is a planned double blind 10 year follow-up, supplemented in more than half of recruits with comprehensive national cancer registry data for up to 20 years.

Supports national guidance

The findings of the study further strengthens the National Institute for Health and Care Excellence (NICE) recommendation on taking daily aspirin for those at high risk and supports wider use of aspirin to prevent cancer.

Based on the preliminary five year data from the CAPP2 trial, NICE recommended that aspirin should be offered for the prevention of bowel cancer in adults with Lynch syndrome.

Professor Sir John Burn, from Newcastle University and Newcastle Hospitals NHS Foundation Trust, who led the research, said the new findings further support this important guidance.

He said: “I had an idea 30 years ago that people with a genetic predisposition to colon cancer could help us to test whether aspirin really could reduce the risk of cancer.

“Patients with Lynch syndrome are high risk and this offered statistical power to use cancer as an endpoint — they are like the canaries in the mine who warned the miners that there was gas.

“It took a long time to start the trial and to recruit enough people in 16 countries, but this study has finally given us an answer.

“Two aspirins a day for a couple of years gives protection that lasts more than 10 years and the statistical analysis has become much stronger with time.

“For people at high cancer risk, the benefits are clear — aspirin works. Our new international trial, CaPP3, will see if smaller doses work just as well.”

Findings showed that when all original recruits were included in the study, those on aspirin had 42% fewer colon cancers. Among those who took the aspirin for a full two years, there were 50% fewer colon cancers.

The study involved 861 patients with Lynch syndrome, which affects about one in 200 people in the population. These people have a genetic problem with DNA repair, making them at much higher risk of cancers such as bowel and womb.

A group of 427 were randomised to aspirin continuously for two years and 434 were allocated to a placebo and then they were all followed for 10 years. Out of those given two aspirins each day (600mg) there were 18 fewer colon cancers, representing a drop of 42.6%.

When all 163 Lynch syndrome cancers are included in the analysis — such as cancer of the endometrium or womb — there was an overall reduced risk of cancer of 24% in those taking aspirin, or 37% in those who took aspirin for the full two years.

Historic background

Between 1999 and 2005 participants began either taking two aspirins every day for two years or a placebo.

At the end of the treatment stage in 2007 there was no overall difference between those who had taken aspirin and those who had not. However, the research team anticipated a longer term effect and designed the study for continued follow-up.

By 2010 there had been 19 new bowel cancers among those who had received aspirin and 34 among those on placebo. The incidence of cancer among the group who had taken aspirin had halved — and the effect began to be seen five years after patients starting taking the aspirin.

Professor Sir John said: “Aspirin has a major preventative effect on cancer but this doesn’t become apparent until at least four years later. With the help of these dedicated volunteers we have learned something of value to us all.

“Before anyone begins to take aspirin on a regular basis they should consult their doctor first as aspirin is known to bring with it a risk of stomach complaints, including ulcers and bleeding.

“However, if there is a strong family history of cancer then people may want to weigh up the cost and health benefits of taking aspirin for at least two years.”

The team are now leading a new international trial, CaPP3, with more than 1,800 people with Lynch syndrome enrolled to look at whether smaller, safer doses of aspirin can be used to help reduce the cancer risk.

The research is funded by Cancer Research UK, NIHR, Bayer Pharma AG and the Barbour Foundation.

Share Button

Coronavirus: England test and trace system identifies 31,000 contacts

The test and trace system identifies 31,000 contacts of people with coronavirus in its first week.

Share Button

Health24.com | An expert breaks down a viral message you’ve likely seen – ‘advice’ from a UK ‘nurse’ on Covid-19

  • Fake coronavirus news continues to spread amid the pandemic
  • A recent viral WhatsApp message offers several Covid-19 recommendations
  • A Wits Professor responds, and separates facts from fiction

Since the outbreak of the new coronavirus, plenty of unreliable and false information has been doing the rounds on several socila media and messaging platforms, including WhatsApp, with many people not always questioning the truth and validity of the messages.

In recent weeks, a lengthy WhatsApp text message has been widely shared, and claims to be “from a GP Nurse in the UK” who put together “some sensible advice” for people who become infected with Covid-19.

Part of the text message reads:

BE PREPARED 

“Everyone is telling you how to NOT catch #coronavirus, but NO ONE is saying what to do if you get it. Thanks to this nurse in the UK for putting this guide together:

“… what I have NOT seen a lot of is advice for what happens if you actually get it, which many of us will. So as your friendly neighbourhood Nurse let me make some suggestions… (sic)” 

Many people are vulnerable to falling for messages such as the above. Health24, therefore, reached out to Professor Susan Goldstein, a public health specialist in the Wits School of Public Health.

Although the original source of the message remains undetermined, Goldstein broke down the contents of the message, setting apart facts from fiction.

Can paracetamol help?

“If affordable take a good general supplement, plus 2 000mg Vit C a day. Include ZINC, SELENIUM & GLUTATHIONE… Scott’s Emulsion is a great general tonic (cod liver oil)… Things you should actually buy ahead of time: *Kleenex*… *Paracetamol* (sic),” the message reads. 

In terms of preparing for getting sick, Goldstein says that having paracetamol (panado) is not a bad idea, as it can be used for any fever.  

“However, the other recommendations are not evidence-based, so the use of 2 000mg Vitamin C a day, zinc, selenium and glutathione [antioxidants], and Scott’s Emulsion is an absolute waste of money,” Goldstein adds. 

Do you need cough medicine and throat spray?

The widely-shared message also mentions that the following should be bought ahead of time:

  • Cough medicine of choice
  • Zinc lozenges
  • Throat spray like Andolex or TCP
  • Vicks VapoRub for your chest
  • A humidifier, or turning up the heat of a shower and sitting in the steam

Goldstein explains that none of the above is evidence-based, but that if you can afford them, they may help ease symptoms. A humidifier is not necessary, though, and while steaming a room may help to make you feel better, it is not a treatment for Covid-19, Goldstein added.

Wearing face masks and gloves

“Wear gloves and a mask to avoid contaminating others in your house,” the message reads. Wearing a cloth mask in public places was announced by President Cryril Ramaphosa as mandatory for all South Africans. According to the National Institute for Communicable Diseases (NICD), there is sufficient evidence to suggest droplet transmission of the Covid-19 virus from each person can be reduced and minimised through mask-wearing.

However, in most situations, such as running errands, wearing gloves is not necessary, explains the Centers for Disease Control and Prevention (CDC).

“Wearing gloves outside of these instances (for example, when using a shopping cart or using an ATM) will not necessarily protect you from getting Covid-19 and may still lead to the spread of germs.

“The best way to protect yourself from germs when running errands and after going out is to regularly wash your hands with soap and water for 20 seconds or use hand sanitiser with at least 60% alcohol,” their website advises.

Alkaline foods as treatment? 

According to the WhatsApp message, “the pH for coronavirus varies from 5.5 to 8.5” and that, to beat the virus, we need to consume alkaline foods that are above the pH level of the virus. It then goes on to recommend certain fruits and vegetables, including lemon, avocado, garlic, and orange.

Goldstein responds: “Once food enters into your stomach, the pH of the food is irrelevant as your stomach has very strong acid which breaks down the various foods. Food stays in your mouth for a relatively short time and is acted upon by various bacteria, so I don’t see how the pH of the food can make any difference.

“The range that is quoted of 5.8-8.5 is very broad, and in fact, the whole idea doesn’t make any sense to me.”

When to seek help

If you experience any symptoms associated with the virus, you should contact your doctor or the SA Covid-19 helpline by calling the official toll free call centre at 0800 029 999, or send “Hi” to 0600 123 456 – the official WhatsApp help service.

Spotting fake news

Shortly after President Ramaphosa declared a national state of disaster earlier this year, regulations that criminalised the intentional distribution of fake news were soon published, reported News24. 

To help prevent the spread of rumours, WhatsApp offers some tips on identifying fake messages. 

READ | Coronavirus in SA: All the confirmed cases

READ | Coronavirus: What are the criteria for a suspected case?

READ | Coronavirus: Basic protective measures

Image: Unsplash/Christian Wiediger

Share Button

Health24.com | Schools, children and Covid-19 risk – experts weigh in

  • In a panel discussion about schools opening, experts emphasised the low-risk of children under 19 when it comes to contracting and spreading the coronavirus
  • Even children with comorbidities like asthma and diabetes – with their condition under control – are deemed to be low-risk
  • Leading paediatric allergologist Professor Eugene Weinberg noted that only 1% of kids who contract Covid-19 have severe symptoms

South African children have slowly started to return to school this week, with many parents still wondering how safe it is in the face of Covid-19.

Experts, however, stand behind the opening of schools, citing that children under the age of 19 are highly unlikely to contract Covid-19 or transmit it. 

In a News24 Frontline panel discussion on Wednesday, Professor Eugene Weinberg – a paediatric allergologist – and Professor Heather Zar – a paediatric pulmonologist – weighed in on the health risks to children going back to school. 

READ: Children and Covid-19: What the latest study says

“Getting the flu is a higher risk than getting Covid-19 for kids,” says Zar, including dying from it. Children have a strong immunity to it, even those with comorbidities like asthma and diabetes – as long as the condition is well-medicated and under control. 

And if children with comorbidities do catch it, symptoms remain mild or kids may even remain asymptomatic. 

She also added that the coronavirus is far more like to spread in an office or grocery store than a school, and if a child catches it they are more likely to have caught it from their parents. 

For those who do contract the virus, only 1% have severe symptoms according to Weinberg, the rest having mild or no symptoms. They are also unlikely to spread it. 

He says many paediatric associations have put their weight behind sending children to school, including for their mental and social well-being. 

“It’s unusual for a child to die from Covid-19, but the ‘What if I’m the statistic?’ is the concern for many parents,” says Weinberg. 

ALSO READ: Kids with cancer not at greater risk for severe Covid-19

What studies say

Around the world, studies have shown resilience in children regarding Covid-19. According to research, less than 2% of reported infections in China, Italy and the US have been in people under the age of 18.

One case investigation published in the American Journal of Roentgenology (AJR) showed that most young patients who contract Covid-19 had normal lungs with little damage. 

While there have been some concerns about an abnormal autoimmune response called Kawasaki disease in children contracting Covid-19, research shows these also to be rare cases. 

There is, however, one study that suggested that obesity seemed to have had some influence in cases where children develop severe symptoms from Covid-19. 

SEE: Similar to adults, obesity raises kids’ odds for severe Covid-19

Mask-wearing remains essential

The most important thing that both Zar and Weinberg encourage is for parents and teachers to be strict with children wearing masks as the best defence. 

It’s something that can be done by everyone – unlike physical distancing and handwashing that can be difficult in certain situations. 

Zar added that with smaller kids where mask-wearing can be problematic, opt for visors as an alternative, but notes that they are far less effective than masks. 

Image credit:

Share Button

Coronavirus: Growing calls for government to scrap 2m rule

Conservative backbenchers say easing the restriction in England is essential for economic recovery.

Share Button

Coronavirus: Major disruption to cancer care revealed

Charities concerned as number of patients seen following an urgent referral by a GP drop in England.

Share Button